Riken Vitamin Co., Ltd.

TSE:4526.T

2597 (JPY) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 91,48488,75079,23177,72282,97489,88889,51587,18188,07285,60385,41977,56875,39877,91276,55078,91580,84280,82179,01173,770
Cost of Revenue 61,59861,50653,66655,71155,51563,51062,42759,85462,14961,08560,50154,93255,00454,05752,89756,99457,40656,41253,92349,585
Gross Profit 29,88627,24425,56522,01127,45926,37827,08827,32725,92324,51824,91822,63620,39423,85523,65321,92123,43624,40925,08824,185
Gross Profit Ratio 0.3270.3070.3230.2830.3310.2930.3030.3130.2940.2860.2920.2920.270.3060.3090.2780.290.3020.3180.328
Reseach & Development Expenses 3,3153,2202,9923,0943,0892,8722,8952,7912,6332,8432,9432,80900000000
General & Administrative Expenses 11,63310,61010,27610,20210,17910,73010,0469,7199,4188,9309,0608,68300000000
Selling & Marketing Expenses 5,3086,0606,2397,1107,4837,4387,6577,5457,6047,8807,6617,31900000000
SG&A 16,94116,67016,51517,31217,66218,16817,70317,26417,02216,81016,72116,00200000000
Other Expenses 259149104252545294-278796520179392389413365339204110189
Operating Expenses 20,51520,08519,72320,64321,06921,32420,82320,26519,89319,86619,89019,03517,82618,26018,79819,06219,82620,93820,95219,018
Operating Income 9,3717,1585,8401,3676,3895,0526,2647,0616,0294,6515,0273,6002,5675,5944,8542,8573,6093,4714,1355,166
Operating Income Ratio 0.1020.0810.0740.0180.0770.0560.070.0810.0680.0540.0590.0460.0340.0720.0630.0360.0450.0430.0520.07
Total Other Income Expenses Net 2,53869914,473-1,374-12,286-3252,013-9137755930759-25-2,658-562-349317799-134
Income Before Tax 11,9097,85720,313-7-5,8976,0448,2776,1486,1065,2515,3343,6592,5422,9364,2922,5083,6403,5484,2345,032
Income Before Tax Ratio 0.130.0890.256-0-0.0710.0670.0920.0710.0690.0610.0620.0470.0340.0380.0560.0320.0450.0440.0540.068
Income Tax Expense 3,1491,440-1,2851,6031,9042,0702,6541,7921,9551,4511,7171,2311,1021,7731,7181,0301,3811,5471,3851,772
Net Income 8,7556,41421,582-1,618-7,8513,9495,6404,3304,1293,7953,5902,4061,4151,1232,5841,5092,2582,0042,8873,264
Net Income Ratio 0.0960.0720.272-0.021-0.0950.0440.0630.050.0470.0440.0420.0310.0190.0140.0340.0190.0280.0250.0370.044
EPS 268.44195.51657.98-49.34-239.45120.46172.6135.0393.7285.8481.1853.3331.2424.7956.2431.9747.8442.4560.568.39
EPS Diluted 268.42195.51657.98-49.34-239.45120.46172.6134.8593.7285.8481.1853.3331.2424.7956.2431.9747.8442.4560.568.39
EBITDA 15,35310,8459,5785,323-2,1808,4969,06410,3169,3968,5548,4357,2766,0096,5428,0626,6068,1857,9857,8537,924
EBITDA Ratio 0.1680.1220.1210.068-0.0260.0950.1010.1180.1070.10.0990.0940.080.0840.1050.0840.1010.0990.0990.107